The hyper IgM syndromes

Nashmia Qamar, Ramsay L Fuleihan*

*Corresponding author for this work

Research output: Contribution to journalReview article

58 Citations (Scopus)

Abstract

The hyper IgM syndromes are a group of rare inherited immune deficiency disorders characterized by impairment of immunoglobulin isotype switching resulting from defects in the CD40 ligand/CD40 signaling pathway. X-linked forms of hyper IgM are caused by defects in the CD40 ligand gene or NF-κB essential modulator, while autosomal recessive forms of hyper IgM are caused by defects in CD40 or downstream signaling molecules including activation-induced cytidine deaminase, uracil N glycosylase or postmeiotic segregation increased 2. The loss of interaction between CD40 and its ligand results in an impairment of T cell function, of B cell differentiation and of monocyte function while only B cell differentiation appears to be affected in defects of sinaling molecules downstream of CD40 with the exception of defects of the NF-κB complex, which mediates signaling via multiple receptor pathways. With many genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitively, to perform genetic screening, and to delineate the clinical manifestations of the different diseases in this syndrome. Stem cell transplantation is an available therapeutic option for defects that result in a combined immunodeficiency while antibody replacement appears sufficient for the strictly humoral immunodeficiencies.

Original languageEnglish (US)
Pages (from-to)120-130
Number of pages11
JournalClinical Reviews in Allergy and Immunology
Volume46
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Hyper-IgM Immunodeficiency Syndrome
CD40 Ligand
Immunoglobulin M
Cell Differentiation
B-Lymphocytes
Uracil-DNA Glycosidase
Immunoglobulin Class Switching
Immunoglobulin Isotypes
Immune System Diseases
Genetic Testing
Stem Cell Transplantation
Monocytes
T-Lymphocytes
Antibodies
Genes
Therapeutics

Keywords

  • CD40
  • CD40 ligand
  • Cryptosporidium
  • Ectodermal dysplasia with immunodeficiency
  • Gene therapy
  • Hyper IgM syndrome
  • Immunoglobulin isotype switching
  • Immunoglobulin replacement therapy
  • Opportunistic infection
  • Pneumocystis jiroveci
  • Registry
  • Stem cell transplantation
  • Switched memory B cells
  • sclerosing cholangitis

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

@article{20ad3241b7414cd7aedaf24dd0e82c76,
title = "The hyper IgM syndromes",
abstract = "The hyper IgM syndromes are a group of rare inherited immune deficiency disorders characterized by impairment of immunoglobulin isotype switching resulting from defects in the CD40 ligand/CD40 signaling pathway. X-linked forms of hyper IgM are caused by defects in the CD40 ligand gene or NF-κB essential modulator, while autosomal recessive forms of hyper IgM are caused by defects in CD40 or downstream signaling molecules including activation-induced cytidine deaminase, uracil N glycosylase or postmeiotic segregation increased 2. The loss of interaction between CD40 and its ligand results in an impairment of T cell function, of B cell differentiation and of monocyte function while only B cell differentiation appears to be affected in defects of sinaling molecules downstream of CD40 with the exception of defects of the NF-κB complex, which mediates signaling via multiple receptor pathways. With many genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitively, to perform genetic screening, and to delineate the clinical manifestations of the different diseases in this syndrome. Stem cell transplantation is an available therapeutic option for defects that result in a combined immunodeficiency while antibody replacement appears sufficient for the strictly humoral immunodeficiencies.",
keywords = "CD40, CD40 ligand, Cryptosporidium, Ectodermal dysplasia with immunodeficiency, Gene therapy, Hyper IgM syndrome, Immunoglobulin isotype switching, Immunoglobulin replacement therapy, Opportunistic infection, Pneumocystis jiroveci, Registry, Stem cell transplantation, Switched memory B cells, sclerosing cholangitis",
author = "Nashmia Qamar and Fuleihan, {Ramsay L}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s12016-013-8378-7",
language = "English (US)",
volume = "46",
pages = "120--130",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "2",

}

The hyper IgM syndromes. / Qamar, Nashmia; Fuleihan, Ramsay L.

In: Clinical Reviews in Allergy and Immunology, Vol. 46, No. 2, 01.01.2014, p. 120-130.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The hyper IgM syndromes

AU - Qamar, Nashmia

AU - Fuleihan, Ramsay L

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The hyper IgM syndromes are a group of rare inherited immune deficiency disorders characterized by impairment of immunoglobulin isotype switching resulting from defects in the CD40 ligand/CD40 signaling pathway. X-linked forms of hyper IgM are caused by defects in the CD40 ligand gene or NF-κB essential modulator, while autosomal recessive forms of hyper IgM are caused by defects in CD40 or downstream signaling molecules including activation-induced cytidine deaminase, uracil N glycosylase or postmeiotic segregation increased 2. The loss of interaction between CD40 and its ligand results in an impairment of T cell function, of B cell differentiation and of monocyte function while only B cell differentiation appears to be affected in defects of sinaling molecules downstream of CD40 with the exception of defects of the NF-κB complex, which mediates signaling via multiple receptor pathways. With many genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitively, to perform genetic screening, and to delineate the clinical manifestations of the different diseases in this syndrome. Stem cell transplantation is an available therapeutic option for defects that result in a combined immunodeficiency while antibody replacement appears sufficient for the strictly humoral immunodeficiencies.

AB - The hyper IgM syndromes are a group of rare inherited immune deficiency disorders characterized by impairment of immunoglobulin isotype switching resulting from defects in the CD40 ligand/CD40 signaling pathway. X-linked forms of hyper IgM are caused by defects in the CD40 ligand gene or NF-κB essential modulator, while autosomal recessive forms of hyper IgM are caused by defects in CD40 or downstream signaling molecules including activation-induced cytidine deaminase, uracil N glycosylase or postmeiotic segregation increased 2. The loss of interaction between CD40 and its ligand results in an impairment of T cell function, of B cell differentiation and of monocyte function while only B cell differentiation appears to be affected in defects of sinaling molecules downstream of CD40 with the exception of defects of the NF-κB complex, which mediates signaling via multiple receptor pathways. With many genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitively, to perform genetic screening, and to delineate the clinical manifestations of the different diseases in this syndrome. Stem cell transplantation is an available therapeutic option for defects that result in a combined immunodeficiency while antibody replacement appears sufficient for the strictly humoral immunodeficiencies.

KW - CD40

KW - CD40 ligand

KW - Cryptosporidium

KW - Ectodermal dysplasia with immunodeficiency

KW - Gene therapy

KW - Hyper IgM syndrome

KW - Immunoglobulin isotype switching

KW - Immunoglobulin replacement therapy

KW - Opportunistic infection

KW - Pneumocystis jiroveci

KW - Registry

KW - Stem cell transplantation

KW - Switched memory B cells

KW - sclerosing cholangitis

UR - http://www.scopus.com/inward/record.url?scp=84896542324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896542324&partnerID=8YFLogxK

U2 - 10.1007/s12016-013-8378-7

DO - 10.1007/s12016-013-8378-7

M3 - Review article

VL - 46

SP - 120

EP - 130

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 2

ER -